<i>In vitro</i> safety and anti‐bacterial efficacy assessment of acriflavine-Reference-Cited by-同舟云学术

In vitro safety and anti‐bacterial efficacy assessment of acriflavine

Published:2022-03-31 Issue:6 Volume:77 Page:1917-1920
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Javadiyan Shari¹²,Germein Kitty C.¹²,Cooksley Clare M.¹²,Ramezanpour Mahnaz¹²^ORCID,Singh Narinder³⁴,Wormald Peter‐John¹²,Vreugde Sarah¹²^ORCID,Psaltis Alkis J.¹²

Affiliation:

1. Department of Otolaryngology Head and Neck Surgery University of Adelaide Adelaide SA Australia

2. Basil Hetzel Institute for Translational Health Research Central Adelaide Local Health Network Adelaide SA Australia

3. Sydney Medical School Faculty of Medicine and Health University of Sydney Sydney NSW Australia

4. Department of Otolaryngology, Head & Neck Surgery Westmead Hospital Sydney NSW Australia

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15289

Reference7 articles.

1. 过敏和鼻科学国际共识声明 : 鼻窦炎

2. Confocal Scanning Laser Microscopy Evidence of Biofilms in Patients With Chronic Rhinosinusitis

3. ClelandEJ BassiouniA WormaldPJ.The bacteriology of chronic rhinosinusitis and the pre‐eminence ofStaphylococcus aureusin revision patients. Paper presented at: International forum of allergy & rhinology2013.

4. Biofilm infections, their resilience to therapy and innovative treatment strategies

5. Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3D-printed implants loaded with acriflavine for glioblastoma treatment;International Journal of Pharmaceutics;2024-09